Evidence map›Paper›PMID 37580388›Full record

ReviewNature cell biology2023

Balancing lysosome abundance in health and disease.

Anders P Mutvei, Michal J Nagiec, John Blenis

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature cell biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Early Transition Metal-Based Antitumor Complexes.Chemistry, an Asian journal · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anders P MutveiDepartment of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Huddinge, Sweden. anders.mutvei@ki.se.ORCID http://orcid.org/0000-0002-2498-5225
Michal J NagiecMeyer Cancer Center and Department of Pharmacology, Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0009-0005-1390-8573
John BlenisMeyer Cancer Center and Department of Pharmacology, Weill Cornell Medical College, New York, NY, USA. jblenis@med.cornell.edu.ORCID http://orcid.org/0000-0003-3622-2337

Funding

SIGNAL TRANSDUCTION TO PP70 S6KR01GM051405 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BLENIS, JOHN · 1995 to 2023
$14.0M
NIGMS NIH HHS R01 GM051405
6 · The paper itself

Abstract

Lysosomes are catabolic organelles that govern numerous cellular processes, including macromolecule degradation, nutrient signalling and ion homeostasis. Aberrant changes in lysosome abundance are implicated in human diseases. Here we outline the mechanisms of lysosome biogenesis and turnover, and discuss how changes in the lysosome pool impact physiological and pathophysiological processes.

Indexed as

LysosomesOrganellesAutophagyHomeostasisHumansSignal Transduction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.